SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (16)4/8/2002 8:01:21 AM
From: nigel bates   of 253
 
Cytokinetics getting some ASCO buzz -

Message 17298596

Other comment -

Industry analysts said the novel cancer drug, one of 161 early-stage projects at GSK, was unlikely to reach the market for 2008, even assuming it proves successful in clinical tests. As such, it has no significant impact on valuations for Europe's biggest drugmaker.
"It does, however, highlight the power of GSK's in-licensing power in finding and obtaining attractive novel therapeutics," ABN AMRO analysts said in a note...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News